Periodic vaccination for post-pandemic management: Insights from and planning beyond COVID-19

References

• Agur, Z., Cojocaru, L., Mazor, G., Anderson, R. M., & Danon, Y. L. (1993). Pulse mass measles vaccination across age cohorts. Proceedings of the National Academy of Sciences of the United States of America, 90(24), 11698–11702. https://doi.org/10.1073/pnas.90.24.11698
   PubMed Web of Science ®Google Scholar
• Alexander, M. E., Moghadas, S. M., Rohani, P., & Summers, A. R. (2006). Modelling the effect of a booster vaccination on disease epidemiology. Journal of Mathematical Biology, 52(3), 290–306. https://doi.org/10.1007/s00285-005-0356-0
   PubMed Web of Science ®Google Scholar
• Anderson, R. M., & May, R. M. (1985). Vaccination and herd immunity to infectious diseases. Nature, 318(6044), 323–329. https://doi.org/10.1038/318323a0
   PubMed Web of Science ®Google Scholar
• Aruffo, E., Yuan, P., Tan, Y., Gatov, E., Gournis, E., Collier, S., Ogden, N., Bélair, J., & Zhu, H. (2022). Community structured model for vaccine strategies to control COVID19 spread: A mathematical study. Plos One, 17(10), e0258648. https://doi.org/10.1371/journal.pone.0258648
   PubMed Web of Science ®Google Scholar
• Bamakan, S. M. H., Malekinejad, P., Ziaeian, M., & Motavali, A. (2021). Bullwhip effect reduction map for COVID-19 vaccine supply chain. Sustainable Operations and Computers, 2, 139–148. https://doi.org/10.1016/j.susoc.2021.07.001
   Google Scholar
• Barda, N., Dagan, N., Cohen, C., Hernán, M. A., Lipsitch, M., Kohane, I. S., Reis, B. Y., & Balicer, R. D. (2021). Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: An observational study. Lancet (London, England), 398(10316), 2093–2100. https://doi.org/10.1016/S0140-6736(21)02249-2
   PubMed Web of Science ®Google Scholar
• Barik, M., Chauhan, S., & Bhatia, S. K. (2020). Efficacy of pulse vaccination over constant vaccination in COVID-19: A dynamical analysis. Communications in Mathematical Biology and Neuroscience, 2020. https://scik.org/index.php/cmbn/article/view/5187
   Google Scholar
• Bevand, M. (2022). COVID19-age-stratified-ifr.
   Google Scholar
• Bubar, K. M., Reinholt, K., Kissler, S. M., Lipsitch, M., Cobey, S., Grad, Y. H., & Larremore, D. B. (2021). Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science (New York, N.Y.), 371(6532), 916–921. https://doi.org/10.1126/science.abe6959
   PubMed Web of Science ®Google Scholar
• Buckner, J. H., Chowell, G., & Springborn, M. R. (2021). Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers. Proceedings of the National Academy of Sciences, 118(16), e2025786118. https://doi.org/10.1073/pnas.2025786118
   Web of Science ®Google Scholar
• Byrne, A. W., McEvoy, D., Collins, A. B., Hunt, K., Casey, M., Barber, A., Butler, F., Griffin, J., Lane, E. A., McAloon, C., O'Brien, K., Wall, P., Walsh, K. A., & More, S. J. (2020). Inferred duration of infectious period of SARS-CoV-2: Rapid scoping review and analysis of available evidence for asymptomatic and symptomatic COVID-19 cases. BMJ Open, 10(8), e039856. https://doi.org/10.1136/bmjopen-2020-039856
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2021). FluVaxView.
   Google Scholar
• Centers for Disease Control and Prevention. (2022a). Frequently Asked Questions about COVID-19 Vaccination.
   Google Scholar
• Centers for Disease Control and Prevention. (2022b). Seasonal Influenza Vaccine Supply for the U.S. 2022–2023. Influenza Season.
   Google Scholar
• Chhatwal, J., Dalgic, O. O., Mueller, P. P., Adee, M., Xiao, Y., Ladd, M. A., Linas, B. P., & Ayer, T. (2020). PIN68 COVID-19 simulator: An interactive tool to inform COVID-19 intervention policy decisions in the United States. Value in Health, 23, S556. https://doi.org/10.1016/j.jval.2020.08.909
   Web of Science ®Google Scholar
• Crellen, T., Pi, L., Davis, E. L., Pollington, T. M., Lucas, T. C. D., Ayabina, D., Borlase, A., Toor, J., Prem, K., Medley, G. F., Klepac, P., & Déirdre Hollingsworth, T. (2021). Dynamics of SARS-CoV-2 with waning immunity in the UK population. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 376(1829), 20200274. https://doi.org/10.1098/rstb.2020.0274
   PubMed Web of Science ®Google Scholar
• Crotty, S. (2021). Hybrid immunity. Science, 372(6549), 1392–1393. https://doi.org/10.1126/science.abj2258
   Web of Science ®Google Scholar
• Dagan, N., Barda, N., Kepten, E., Miron, O., Perchik, S., Katz, M. A., Hernán, M. A., Lipsitch, M., Reis, B., & Balicer, R. D. (2021). BNT162b2 mRNA Covid-19 vaccine in a nationwide mass vaccination setting. The New England Journal of Medicine, 384(15), 1412–1423. https://doi.org/10.1056/NEJMoa2101765
   PubMed Web of Science ®Google Scholar
• Dan, J. M., Mateus, J., Kato, Y., Hastie, K. M., Yu, E. D., Faliti, C. E., Grifoni, A., Ramirez, S. I., Haupt, S., Frazier, A., Nakao, C., Rayaprolu, V., Rawlings, S. A., Peters, B., Krammer, F., Simon, V., Saphire, E. O., Smith, D. M., Weiskopf, D., Sette, A., & Crotty, S. (2021). Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science (New York, N.Y.), 371(6529), eabf4063. https://doi.org/10.1126/science.abf4063
   PubMed Web of Science ®Google Scholar
• Dong, E., Du, H., & Gardner, L. (2020). An interactive web-based dashboard to track COVID-19 in real time. The Lancet. Infectious Diseases, 20(5), 533–534. https://doi.org/10.1016/S1473-3099(20)30120-1
   PubMed Web of Science ®Google Scholar
• Doria-Rose, N., Suthar, M. S., Makowski, M., O'Connell, S., McDermott, A. B., Flach, B., Ledgerwood, J. E., Mascola, J. R., Graham, B. S., Lin, B. C., O'Dell, S., Schmidt, S. D., Widge, A. T., Edara, V.-V., Anderson, E. J., Lai, L., Floyd, K., Rouphael, N. G., Zarnitsyna, V., … Kunwar, P. (2021). Antibody persistence through 6 months after the second dose of mRNA-1273 vaccine for Covid-19. The New England Journal of Medicine, 384(23), 2259–2261. https://doi.org/10.1056/NEJMc2103916
   PubMed Web of Science ®Google Scholar
• Etxeberria-Etxaniz, M., Alonso-Quesada, S., & De la Sen, M. (2020). On an SEIR epidemic model with vaccination of newborns and periodic impulsive vaccination with eventual on-line adapted vaccination strategies to the varying levels of the susceptible subpopulation. Applied Sciences, 10(22), 8296. https://doi.org/10.3390/app10228296
   Google Scholar
• Gao, S., Chen, L., Nieto, J. J., & Torres, A. (2006). Analysis of a delayed epidemic model with pulse vaccination and saturation incidence. Vaccine, 24(35–36), 6037–6045. https://doi.org/10.1016/j.vaccine.2006.05.018
   PubMed Web of Science ®Google Scholar
• Giannitsarou, C., Kissler, S., & Toxvaerd, F. (2021). Waning immunity and the second wave: Some projections for SARS-CoV-2. American Economic Review: Insights, 3(3), 321–338. https://doi.org/10.1257/aeri.20200343
   Google Scholar
• Haas, E. J., Angulo, F. J., McLaughlin, J. M., Anis, E., Singer, S. R., Khan, F., Brooks, N., Smaja, M., Mircus, G., Pan, K., Southern, J., Swerdlow, D. L., Jodar, L., Levy, Y., & Alroy-Preis, S. (2021). Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: An observational study using national surveillance data. Lancet (London, England), 397(10287), 1819–1829. https://doi.org/10.1016/S0140-6736(21)00947-8
   PubMed Web of Science ®Google Scholar
• Heffernan, J. M., & Keeling, M. J. (2009). Implications of vaccination and waning immunity. Proceedings of the Royal Society. Proceedings. Biological Sciences, 276(1664), 2071–2080. https://doi.org/10.1098/rspb.2009.0057
   PubMed Web of Science ®Google Scholar
• Hurtado, P. J., & Kirosingh, A. S. (2019). Generalizations of the ‘Linear Chain Trick’: Incorporating more flexible dwell time distributions into mean field ODE models. Journal of Mathematical Biology, 79(5), 1831–1883. https://doi.org/10.1007/s00285-019-01412-w
   PubMed Web of Science ®Google Scholar
• Hurtado, P. J., & Richards, C. (2021). Building mean field ODE models using the generalized linear chain trick & Markov chain theory. Journal of Biological Dynamics, 15(sup1), S248–S272. https://doi.org/10.1080/17513758.2021.1912418
   PubMedGoogle Scholar
• Kissler, S. M., Tedijanto, C., Goldstein, E., Grad, Y. H., & Lipsitch, M. (2020). Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science (New York, N.Y.), 368(6493), 860–868. https://doi.org/10.1126/science.abb5793
   PubMed Web of Science ®Google Scholar
• Lu, Z., Chi, X., & Chen, L. (2002). The effect of constant and pulse vaccination on SIR epidemic model with horizontal and vertical transmission. Mathematical and Computer Modelling, 36(9–10), 1039–1057. https://doi.org/10.1016/S0895-7177(02)00257-1
   Google Scholar
• Mak, H.-Y., Dai, T., & Tang, C. S. (2021). Managing two-dose COVID-19 vaccine rollouts with limited supply: Operations strategies for distributing time-sensitive resources. SSRN Scholarly Paper ID 3790836. Social Science Research Network.
   Google Scholar
• Mathieu, E., Ritchie, H., Ortiz-Ospina, E., Roser, M., Hasell, J., Appel, C., Giattino, C., & Rodés-Guirao, L. (2021). A global database of COVID-19 vaccinations. Nature Human Behaviour, 5(7), 956–959.
   PubMed Web of Science ®Google Scholar
• Matrajt, L., Eaton, J., Leung, T., & Brown, E. R. (2021). Vaccine optimization for COVID-19: Who to vaccinate first? Science Advances, 7(6), eabf1374. https://doi.org/10.1126/sciadv.abf1374
   PubMed Web of Science ®Google Scholar
• Monto, A. S. (2021). The future of SARS-CoV-2 vaccination—Lessons from influenza. The New England Journal of Medicine, 385(20), 1825–1827. https://doi.org/10.1056/NEJMp2113403
   PubMed Web of Science ®Google Scholar
• Nokes, D. J., & Anderson, R. M. (1988). The use of mathematical models in the epidemiological study of infectious diseases and in the design of mass immunization programmes. Epidemiology and Infection, 101(1), 1–20. https://doi.org/10.1017/s0950268800029186
   PubMed Web of Science ®Google Scholar
• Pfizer Inc. (2020). Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints. | Pfizer.
   Google Scholar
• Schulze, C., Welker, A., Kühn, A., Schwertz, R., Otto, B., Moraldo, L., Dentz, U., Arends, A., Welk, E., Wendorff, J.-J., Koller, H., Kuss, D., & Ries, M. (2021). Public health leadership in a VUCA world environment: Lessons learned during the regional emergency rollout of SARS-CoV-2 vaccinations in Heidelberg, Germany, during the COVID-19 pandemic. Vaccines, 9(8), 887. https://doi.org/10.3390/vaccines9080887
   Web of Science ®Google Scholar
• Shulgin, B., Stone, L., & Agur, Z. (1998). Pulse vaccination strategy in the SIR epidemic model. Bulletin of Mathematical Biology, 60(6), 1123–1148. https://doi.org/10.1016/S0092-8240(98)90005-2
   PubMed Web of Science ®Google Scholar
• Stein, C., H., Nassereldine, R. J. D., Sorensen, J. O., Amlag, C., Bisignano, S., Byrne, E., Castro, K., Coberly, J. K., Collins, J., Dalos, F., Daoud, A., Deen, E., Gakidou, J. R., Giles, E. N., Hulland, B. M., Huntley, K. E., Kinzel, R., Lozano, A. H., Mokdad, C. J. L., Murray, … Lim, S. S.. (2023). Past SARS-CoV-2 infection protection against re-infection: A systematic review and meta-analysis. The Lancet, 401(10379), 833–842. https://doi.org/10.1016/S0140-6736(22)02465-5
   PubMed Web of Science ®Google Scholar
• Torjesen, I. (2021). Covid-19 will become endemic but with decreased potency over time, scientists believe. BMJ (Clinical Research ed.), 372, n494. https://doi.org/10.1136/bmj.n494
   PubMedGoogle Scholar
• Townsend, J. P., Hassler, H. B., Wang, Z., Miura, S., Singh, J., Kumar, S., Ruddle, N. H., Galvani, A. P., & Dornburg, A. (2021). The durability of immunity against reinfection by SARS-CoV-2: A comparative evolutionary study. The Lancet. Microbe, 2(12), e666–e675. https://doi.org/10.1016/S2666-5247(21)00219-6
   PubMedGoogle Scholar
• WHO Global Influenza Programme and World Health Organization. (2009). Pandemic influenza preparedness and response : a WHO guidance document. Technical report, World Health Organization. ISBN: 9789241547680 number-of-pages: 60.
   Google Scholar
• Xin, H., Li, Y., Wu, P., Li, Z., Lau, E. H. Y., Qin, Y., Wang, L., Cowling, B. J., Tsang, T. K., & Li, Z. (2021). Estimating the latent period of coronavirus disease 2019 (COVID-19). Clinical Infectious Diseases, 74(9), 1678–1681. https://doi.org/10.1093/cid/ciab746
   Google Scholar
• Zhou, Y., & Liu, H. (2003). Stability of periodic solutions for an SIS model with pulse vaccination. Mathematical and Computer Modelling, 38(3–4), 299–308. https://doi.org/10.1016/S0895-7177(03)90088-4
   Google Scholar